160 related articles for article (PubMed ID: 30880750)
1. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
[TBL] [Abstract][Full Text] [Related]
2. CDH1 promoter polymorphism (-347G-->GA) is a possible prognostic factor in sporadic colorectal cancer.
Zou XP; Dai WJ; Cao J
World J Gastroenterol; 2009 Nov; 15(42):5340-5. PubMed ID: 19908344
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
Ye CC; Wang J
J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324
[TBL] [Abstract][Full Text] [Related]
4. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.
Grünhage F; Jungck M; Lamberti C; Berg C; Becker U; Schulte-Witte H; Plassmann D; Rahner N; Aretz S; Friedrichs N; Buettner R; Sauerbruch T; Lammert F
Int J Colorectal Dis; 2008 Feb; 23(2):147-54. PubMed ID: 17960397
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
[TBL] [Abstract][Full Text] [Related]
6. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.
Li W; Xiao D; Wu H; Xu L
Clin Exp Med; 2020 Feb; 20(1):73-78. PubMed ID: 31625007
[TBL] [Abstract][Full Text] [Related]
7. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
[TBL] [Abstract][Full Text] [Related]
8. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
9. The E-cadherin (CDH1) -C160A polymorphism and colorectal cancer susceptibility: a meta-analysis.
Geng P; Chen Y; Ou J; Yin X; Sa R; Liang H
DNA Cell Biol; 2012 Jun; 31(6):1070-7. PubMed ID: 22339265
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
11. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
[TBL] [Abstract][Full Text] [Related]
12. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
[TBL] [Abstract][Full Text] [Related]
13. Association of CDH1 and TERT Single-Nucleotide Polymorphisms with Susceptibility to Familial Breast Cancer Risk.
Bagherpour M; Gharibzad K; Rassi H
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):239-244. PubMed ID: 30543312
[TBL] [Abstract][Full Text] [Related]
14. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
15. Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.
Sun N; Chen J; Hu G; Chen X; Jiang J; Zhang L; Wu H
Crit Rev Eukaryot Gene Expr; 2017; 27(4):347-354. PubMed ID: 29283329
[TBL] [Abstract][Full Text] [Related]
16. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer.
Chien MH; Chou LS; Chung TT; Lin CH; Chou MY; Weng MS; Yang SF; Chen MK
Head Neck; 2012 Mar; 34(3):405-11. PubMed ID: 21472888
[TBL] [Abstract][Full Text] [Related]
17. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.
Wheeler JM; Kim HC; Efstathiou JA; Ilyas M; Mortensen NJ; Bodmer WF
Gut; 2001 Mar; 48(3):367-71. PubMed ID: 11171827
[TBL] [Abstract][Full Text] [Related]
19. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
[TBL] [Abstract][Full Text] [Related]
20. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
